Napomena: Rok za dostavljanje primedbi na doktorsku disertaciju je istekao.
Datum postavljanja na uvid javnosti: 12-05-2025
Objavljeni radovi:
[1] Kokanov NS, Krajnović MM, Ćupić-Jovanović SP, Kožik BR, Petrović NM, Božović AM, Mandušić VL. RASSF1A and p16 promoter methylation and treatment response in chronic hepatitis C genotype 1b patients treated with pegylated interferon/ribavirin. Archives of Biological Sciences. 2022;74(1):57-66. M23 https://doiserbia.nb.rs/Article.aspx?id=0354-46642200004K
[2] Kokanov N, Jovanović-Ćupić S, Šiljić M, Ćirković V, Petrović N, Kožik B, Krajnović M. Variability of the HCV core region and host genetic and epigenetic factors can predict the response to pegylated interferon/ribavirin therapy in genotype 1b hepatitis C patients from Serbia. Archives of Biological Sciences. 2023;75(3):251-62. M23 https://doiserbia.nb.rs/Article.aspx?id=0354-46642300020K
